Naprosyn (Naproxen)

Naproxen works by reversibly blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for prostaglandin synthesis. By lowering prostaglandin levels, the drug diminishes the signals that cause pain, swelling, and fever, providing analgesic, anti‑inflammatory, and antipyretic effects.

The appropriate dose of Naprosyn is determined by the prescribing healthcare professional based on the individual’s condition, age, renal function, and other factors. Typical adult regimens range from 250 mg to 500 mg taken twice daily, but exact dosing must follow the prescriber’s instructions.

The safety of naproxen in pregnancy and lactation has not been definitively established. It is generally advised to avoid use during the third trimester and to discuss potential risks with a healthcare provider before taking the medication while pregnant or breastfeeding.

To order Naprosyn, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with ibuprofen, another widely used NSAID, naproxen has a longer half‑life, allowing twice‑daily dosing rather than three‑ or four‑times daily. Both share similar efficacy for pain and inflammation, but naproxen may carry a slightly higher cardiovascular risk in long‑term use, which clinicians consider when selecting therapy.

Naprosyn should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Naprosyn is administered orally, typically as a tablet swallowed whole with a full glass of water. It may be taken with food or milk to lessen gastrointestinal discomfort, but patients should follow the specific instructions provided by their prescriber.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, renal impairment, and severe skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience black stools, sudden chest pain, shortness of breath, swelling of the legs, or a rash.

Naprosyn is contraindicated in individuals with a known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulceration or bleeding, severe heart failure, and those who have had a recent myocardial infarction or stroke. It should also be avoided in patients with advanced renal or hepatic disease unless specifically directed by a physician.